CNS Pharmaceuticals, Inc. Rings the Opening Bell
ABOUT THIS EVENT
CNS Pharmaceuticals, Inc. (Nasdaq: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers of the brain and central nervous system, visited the Nasdaq MarketSite in Times Square.
In honor of the occasion, John Climaco, CEO, rang the Opening Bell.